Turning a Negative into a Positive: Vitamin D Receptor Interactions with the Avian Parathyroid Hormone Response Element
Nicholas J. Koszewski,
Sheila Ashok and
John Russell
Department of Internal Medicine (N.J.K.) Division of
Nephrology, Bone and Mineral Metabolism University of Kentucky
Medical Center Lexington, Kentucky 40536-0084
Department
of Medicine (S.A., J.R.) Albert Einstein College of Medicine
Bronx, New York 10021
 |
ABSTRACT
|
---|
1,25-Dihydroxyvitamin D3
[1,25-(OH)2D3]
negatively regulates expression of the avian PTH (aPTH) gene
transcript, and a vitamin D response element (VDRE) near the promoter
of the aPTH gene had previously been identified. The present report
assessed whether the negative activity imparted by the aPTH VDRE could
be converted to a positive transcriptional response through selective
mutations introduced into the element. The tested sequences were
derived from individual and combined mutations to 2 bp in the 3'-half
of the direct repeat element, GGGTCAggaGGGTGT. Cold
competition experiments using mutant and wild-type oligonucleotides in
the mobility shift assay revealed minor differences in the ability of
any of these sequences to compete for binding to a heterodimer complex
comprised of recombinant proteins. Ethylation interference footprint
analysis for each of the mutants produced unique patterns over the
3'-half-sites that were distinct from the weak, wild-type footprint.
Transcriptional outcomes evaluated from a chloramphenicol
acetyltransferase reporter construct utilizing the aPTH promoter
found that the individual T
A mutant produced an attenuated negative
transcriptional response while the G
C mutant resulted in a
reproducibly weak positive transcriptional outcome. The double mutant,
however, yielded a 4-fold increase in transcription, similar to the
7-fold increase observed from an analogous construct using the human
osteocalcin VDRE. UV light cross-linking to gapped oligonucleotides
assessed the polarity of heterodimer binding to the wild-type and
double mutant sequences and was consistent with the vitamin D receptor
preferentially binding to the 5'-half of both elements. Finally, DNA
affinity chromatography was used to immobilize heterodimer complexes
bound to the wild-type and double mutant sequences as bait to identify
proteins that may preferentially interact with these DNA-bound
heterodimers. This analysis revealed the presence of a p160 protein
that specifically interacted with the heterodimer bound to the
wild-type VDRE, but was absent from complexes bound to response
elements associated with positive transcriptional activity. Thus, the
sequence of the individual VDRE appears to play an active role in
dictating transcriptional responses that may be mediated by
altering the ability of a vitamin D receptor heterodimer to interact
with accessory factor proteins.
 |
INTRODUCTION
|
---|
The hormonal form of vitamin D, 1,25-dihyroxyvitamin
D3 [1,25-(OH)2D3], binds to its
receptor to regulate the transcriptional activity of numerous genes
(for review see Ref. 1). A number of DNA response elements to which the
hormone-receptor complex binds with high affinity have been identified
(2, 3, 4, 5, 6, 7, 8). The majority of known vitamin D response elements (VDREs)
follow a direct repeat with 3-bp spacing (DR+3) format (7) and are
associated with positive or increased transcription of the target gene
message. With few exceptions (9, 10, 11, 12), high-affinity DNA-binding
interactions by the vitamin D receptor (VDR) require heterodimerization
with an accessory nuclear factor (13, 14, 15, 16), currently thought to consist
of members of the retinoid X receptor (RXR) family of proteins
(17, 18, 19). However, binding by a heterodimer to a DR+3 element implies
an inherent polarity regarding the positioning of the individual
proteins over each of the half-sites of the element. Recent results
would suggest that the preferred orientation on the osteopontin and
osteocalcin VDREs, sequences associated with positive gene-regulatory
activity by the vitamin, place the VDR over the 3'-half-site with RXR
occupying the 5' half-site (20, 21, 22).
The hormone, however, also negatively regulates expression of several
gene products (23, 24, 25, 26, 27), including direct transcriptional effects on PTH
gene expression (28, 29, 30, 31, 32). Response elements were identified that were
in close proximity to the promoters of the avian and human PTH genes
(28, 29). The avian PTH (aPTH) VDRE followed the classical DR+3 format
while the hPTH VDRE appeared to function as a single half-site and may
involve RXR-independent binding (33). In vitro DNA binding
to the aPTH VDRE was shown to require heterodimerization of recombinant
VDR with RXR-containing extracts, although interference footprinting
results revealed only weak interactions over the two half-sites (29).
As part of the same study, transient transfection experiments utilizing
the aPTH VDRE demonstrated the elements ability to down-regulate gene
expression in response to hormone, either within the context of its
natural position in the aPTH promoter or when linked to a heterologous
promoter.
Negative gene regulation by other members of the steroid hormone
receptor superfamily has also been described. Negative regulation of
the bovine PRL gene by glucocorticoids was shown to occur by direct
interaction of the glucocorticoid receptor with a negative
glucocorticoid response element (GRE) that bore only a modest
resemblance to a consensus GRE derived from positive regulatory
elements (34, 35). Interestingly, when two mutations were introduced
into this negative element, the transcriptional activity was
transformed from negative to positive in response to hormone
administration. That data, combined with additional evidence that GREs
may act as allosteric regulators of glucocorticoid-mediated gene
transcription (36, 37), give credence to the notion that individual DNA
sequences may play an active role in dictating transcriptional
responses.
As part of continuing studies on the aPTH gene, we noted that
replacement of the wild-type negative VDRE in the aPTH promoter with
the positively responding human osteocalcin (hOC) VDRE resulted in a
strong positive transcriptional response to
1,25-(OH)2D3 administration in transient
transfection studies (see Table 1
). This
indicated that the aPTH promoter could support both negative or
positive transcriptional outcomes and suggested that the DNA sequence
of the VDRE may actively participate in dictating the observed
response. Given these preliminary observations, we systematically
investigated the capacity to alter the negative transcriptional
potential of the aPTH VDRE by directed mutagenesis of the wild-type
element within the context of its natural promoter.
 |
RESULTS
|
---|
Sequence comparisons with DR+3 VDREs known to elicit positive
transcriptional responses (2, 3, 4, 5, 6, 7, 8), as well as comprehensive footprint
data on positive VDREs (11), indicated the presence of highly conserved
nucleotides throughout these motifs. Analysis of the aPTH VDRE revealed
that it bore striking similarity to these sequences, save for the
latter two positions in the 3'-half of the element (+6 and +7, Fig. 1
). These positions are largely
restricted to cytosine (+6) and adenine (+7) residues in the majority
of positive VDREs, but are relegated to guanine and thymidine residues
in the wild-type aPTH element. Thus, in the present study, mutations
were introduced into these positions comprised of single conversions of
G
C at +6 (cPTH) and T
A at the +7 position (mPTH) because of the
aforementioned high conservation of those nucleotides in positive DR+3
VDREs. A double mutant (dmPTH) was also created by changing the GT at
positions +6/+7 to CA to generate a perfect direct repeat of the GGGTCA
hexanucleotide half-site, similar to a sequence previously shown to be
an enhancer of vitamin D actions (7). Notably, this represents a
conversion from a purine/pyrimidine to a pyrimidine/purine dinucleotide
ending.

View larger version (32K):
[in this window]
[in a new window]
|
Figure 1. Sequences and Numbering Scheme of DR+3 Sequences
Used in the Study
Sequence of the aPTH VDRE is highlighted with the
numbering scheme of the various nucleotide positions listed
above. Shown below are the sequences of
the mutants and the positive control hOC VDRE. Abbreviations are
defined in the text.
|
|
Specific binding to the aPTH sequence was evaluated in the gel shift
assay using recombinant human VDR (rhVDR) and RXR
(rhRXR
)
extracts (Fig. 2
). No binding was
observed by either extract alone (lanes 1 and 2), and while binding was
observed in the absence of hormone, addition of
1,25-(OH)2D3 resulted in a 2-fold stimulation
of binding under these conditions (lanes 3 and 4). The anti-VDR
antibody, 9A7
, was able to block the appearance of the bound band
while generating a minor supershifted complex, and inclusion of an
anti-RXR
antibody was able to supershift the complex indicating that
both proteins were part of the bound complex (lanes 5 and 11).
Competition with an excess of unlabeled aPTH or hOC double-stranded
oligonucleotides prevented observation of the bound radiolabeled
complex, while the perfect estrogen response element from the chicken
vitellogenin II (cvitERE) gene had no effect on the complex (lanes
79). Analogous results were obtained using radiolabeled probes for
each of the other mutant aPTH VDRE sequences (data not shown),
indicating that the mixture of rhVDR/rhRXR
was required and bound to
the these sequences in a specific manner.
Relative competitive binding curves were generated for the heterodimer
complex using a fixed amount of radiolabeled aPTH VDRE and varying
concentrations of the cold wild-type and mutant oligonucleotides (Fig. 3
). Based on an analysis of the
half-maximal competition curves, the data indicate that the dmPTH
oligonucleotide was approximately 3 to 4 times more effective at
competing for heterodimer binding to the aPTH probe than either the
wild-type sequence or the cPTH mutant oligonucleotide. The mPTH
sequence was the least effective competitor of these four
oligonucleotides in this analysis. Furthermore, additional mutant
oligonucleotides were evaluated that replaced highly conserved guanine
dinucleotide positions in the 5'-half of the wild-type element (5'Mut,
positions -5 and -6, GG
CC) or in the 3'-half of the element
(3'Mut, positions +3 and +4, GG
CC). Neither of these latter mutants
was effective at competing for binding by the heterodimer, although the
3'Mut, which retained the intact GGGTCA 5'-half-site, produced a modest
reduction in the bound band at the highest tested concentration. This
indicates the importance of both half-sites in binding by the
heterodimeric complex.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 3. Competition of Wild-Type and Mutant
Oligonucleotides for Binding to the Wild-Type Element
Variable amounts of aPTH (open squares), mPTH
(solid squares), cPTH (solid triangles),
dmPTH (solid diamonds), 5'Mut (cross-marks), and 3'Mut
(open diamonds) oligonucleotides were mixed with a fixed
amount of radiolabeled aPTH VDRE in gel shift experiments using a
constant concentration of rhVDR/rhRXR heterodimer. After separation
of bound and free probe, the samples were analyzed for the amount of
bound complex and normalized against a control binding reaction of the
heterodimer with no cold competitor added. Shown are the average values
and SEs from two (5'- and 3'Mut) or three (all others)
independent experiments.
|
|
Earlier interference footprint studies examining the interactions of
partially purified canine intestinal VDR with the aPTH VDRE revealed a
group of weak, major groove contact points in the DR+3 element (29). In
an effort to discern potential differences in DNA-binding interactions,
ethylation interference footprints were generated for the recombinant
proteins bound to the wild-type and mutant sequences. Ethylation of the
wild-type probe and its use in the interference assay with the
recombinant proteins revealed a footprint analogous to that produced by
the canine VDR and consistent with dimer binding (Fig. 4a
). Weak interference was observed over
the modified guanines at positions -7 to -5 and +2 to +4. On the
opposite strand (data not shown), weak interference was again seen over
the TGA sequence at -2' to -4', with even less pronounced
interactions over the ACA at +5' to +7'.

View larger version (48K):
[in this window]
[in a new window]
|
Figure 4. Ethylation Interference Analysis of Binding to the
aPTH and Mutant Sequences
Ethylation interference was used to examine binding by the
rhVDR/rhRXR heterodimer to the aPTH (a), mPTH (b), cPTH (c), and
dmPTH (d) modified probes. Sequences are indicated, and the
corresponding guanine triplet areas are bracketed. B,
Bound fraction from mobility shift separation; F, free probe from
mobility shift separation; C, a portion of each ethylated probe was
withheld from the footprint analysis and treated in an analogous
fashion to the B and F samples to generate a control cleavage pattern.
It was noted that significantly less F sample was evident in the
mobility shift separation using the dmPTH-modified probe; thus, the
decreased intensity of noninterfering bands was observed in the
subsequent cleavage and sequencing gel analysis. (e) Overlays of the
footprints from the 3'-halves of each of the sequences in panels ad
is shown (solid lines). For comparative purposes, an
overlay of the control cleavage (C) of the ethylated aPTH sequence
(dashed line) is included as a point of reference in
each case.
|
|
The interference footprint of the top strand of the mPTH mutant
exhibited a modest departure from the wild-type sequence (Fig. 4b
).
Notably, interactions were again evident at the +2 to +4 guanine
positions, but they now displayed a measurable increase in the degree
of interference, with the strongest occurring at the +2 and +3
positions. The opposite strand exhibited a slight gain in interference
over the +5' to +7' positions (data not shown). The strands of the
other single mutant, cPTH, produced a unique footprint pattern that was
now significantly altered from the previous observations (Fig. 4c
).
Interference over the guanine triplet at +2 to +4 was again evident;
however, very strong interference was now observed over the modified
guanine at +3, with a more modest gain in interference evident at the
+4 guanine. Significant increases in interference were also observed
over the -7 to -5 guanine triplet in the 5'-half of the element as
well as additional degrees of contact over the corresponding AGA at +5'
to +7' on the opposite strand (data not shown).
The interference footprint of the double mutant deviated significantly
from the previously examined wild-type and single-mutant sequences
(Fig. 4d
). Strong, nearly complete interference was observed over the
guanine residues at +2/+3, and as noted for the cPTH mutant, there was
significant interference over the guanines at -5/-6. In addition,
interference in the opposite strand was now strongly evident over the
pair of TGA sequences at +5' to +7' and -2' to -4' (data not shown).
The overall pattern of interference for the dmPTH was similar in nature
to the strong interference seen for the osteopontin (11) and
osteocalcin VDREs (N. J. Koszewski, unpublished observations),
both of which are known to be strong positive regulators of vitamin
D-stimulated gene transcription (2, 3, 5). A densitometric analysis is
presented in Fig. 4e
to depict the changes that occurred in the
footprint patterns over the 3'-halves of each of the sequences. These
range from a very modest degree of interference observed as a result of
the heterodimer complex binding to the wild-type aPTH VDRE to the very
strong, almost complete, interference observed with the dmPTH sequence.
As an initial point of reference, a control cleavage pattern generated
from a portion of the chemically modified aPTH VDRE probe not used in
the separation analysis is also included in each graph (dashed
line).
Ribonuclease protection assays were next used to assess the
transcriptional response to administration of
1,25-(OH)2D3 to OK cells transfected with
reporter constructs containing wild-type or mutant VDREs upstream from
the aPTH promoter linked to the chloramphenicol acetyl transferase
(CAT) gene (Table 1
). In transfection studies using plasmid constructs
containing the wild-type aPTH VDRE, treatment with
1,25-(OH)2D3 inhibited CAT mRNA transcripts by
54%, similar to earlier observations using CAT enzyme activity itself
to assess gene expression (29). Substitution of the wild-type sequence
with the mPTH VDRE resulted in approximately 50% attenuation of the
inhibitory effect of 1,25-(OH)2D3 (-54%
vs. -28%). More interestingly, the single mutation of
G
C at position +6 (cPTH) now resulted in a modest, but highly
reproducible, increase (+21%) of CAT gene transcripts in response to
hormone. Finally, transfection with the plasmid construct containing
the dmPTH sequence resulted in a dramatic increase (
4-fold) in CAT
gene transcription, similar to the 7-fold increase observed with the
prototypical positive hOC VDRE used as a positive control in these
experiments.
Selected mutations within the wild-type aPTH response element were able
to alter the points of DNA contact as delineated by the interference
assay in conjunction with a graded response from negative to positive
in hormone-stimulated transcriptional activity. However, heterodimeric
interactions by the RXR/VDR complex with a direct repeat response
element implies an order or polarity of the individual proteins with
respect to DNA binding. Previous studies demonstrated that RXR occupies
the 5'-half and VDR the 3'- half of VDREs isolated from genes that are
up-regulated by the vitamin (20, 21, 22, 38). In light of the negative
regulation imparted by the wild-type aPTH sequence, and the clearly
positive response obtained with the dmPTH element, we sought to
ascertain whether this might not be the result of an altered polarity
of the proteins binding to these elements. Using a strategy of gapped
oligonucleotides and UV light cross-linking (39), proteins in contact
with the 5'- and 3'-halves of both of these VDREs were analyzed.
As noted in Fig. 5
, cross-linking to
either half of both the aPTH and dmPTH sequences gave similar results.
Control cross-linking to either 5' sequence yielded two prominent bands
at approximately 59 and 82 kDa, which was consistent with linked
oligonucleotides to rhVDR and rhRXRß, respectively. Specific
competition with an excess amount of hOC VDRE resulted in the
disappearance of both bands; however, competition with an excess of the
nonspecific cvitERE had a dramatic effect on either eliminating or
strongly reducing the intensity of the 82-kDa band, while a more modest
effect on the 59-kDa band was observed. This suggests that the 82-kDa
band is not specific and these results would be consistent with a
polarity of binding that places rhVDR in the 5'-position. Using the
same type of analysis, cross-linking to the 3'-halves of both elements
resulted in the most prominent, specific band at 82 kDa, indicative
of hRXRß linked to the respective 3'-oligonucleotides. Thus, while
the polarity appears reversed for the wild-type negative element from
other known positive VDREs, this alignment is maintained in the dmPTH
mutant sequence that elicits a positive transcriptional response.
Therefore, an altered polarity by itself cannot account for the
negative to positive transcriptional response observed with these two
sequences.

View larger version (65K):
[in this window]
[in a new window]
|
Figure 5. UV Cross-Linking of Gapped, Radiolabeled 5'- and
3'-Oligonucleotides Corresponding to the aPTH or dmPTH Sequences
Recombinant hVDR and hRXRß cytosols were mixed with the appropriately
labeled gapped oligonucleotides and irradiated at 254 nm, and the
products were separated by SDS-PAGE. C, Control binding conditions;
hOC, a 200-fold excess of unlabeled osteocalcin probe was added to the
binding reaction before cross-linking; ERE, a 200-fold excess of
unlabeled cvitERE was added to the binding reaction before
cross-linking. Recombinant hRXRß was used in this experiment as it
offered a clearer separation of denatured proteins (recombinant
hVDR = 4950 kDa; hRXRß = 6870 kDa).
|
|
The polarity of binding by the heterodimer appeared the same for these
two elements, yet there were distinct changes in the footprint patterns
that suggested a difference in the manner in which the heterodimer
bound to one sequence vs. the other. Given this possibility,
we assessed whether there might be differences in proteins that may
interact with the heterodimer bound to these two sequences. To test
this scenario, oligonucleotide matrices were generated for either the
wild-type or double-mutant sequences. These were prebound with
saturating concentrations of recombinant extracts of rhVDR/rhRXR
in
the presence of 1,25-(OH)2D3 and washed with a
moderately high-salt (200 mM KCl) buffer to limit binding
by nonspecific proteins. These matrices were then equilibrated in a
low-salt buffer and incubated with extracts prepared from MG-63 cells,
a human osteoblastic cell line, that permitted having human recombinant
receptors interacting with human-derived cofactors. After this, the
matrices were washed extensively with low-salt buffer, and all of the
proteins were recovered in a high-salt wash and analyzed by SDS-PAGE
and silver staining. As a further set of controls, the hOC VDRE and a
DR+1 known to bind RXR homodimers (40, 41) were similarly prepared. In
the latter case, the column was prebound with rhRXR
extracts alone
in the presence of 9-cis-retinoic acid.
As expected, rhVDR and rhRXR
were readily evident in the elutions
from the matrices in comparable amounts (Fig. 6
). Several proteins, including a cluster
in the range of 4547 kDa and a 240-kDa band, appeared in all four
eluted samples, although the 45-kDa band was more prominently observed
in the hOC elution with little of the 47-kDa band evident. In addition,
a protein at 50 kDa appeared more intensely in the elutions from the
columns bound with VDR/RXR
heterodimer complexes than in the
rhRXR
homodimer experiment. A pair of intense bands at approximately
60 and 54 kDa from the MG-63 cell extract, above and below the position
of rhRXR
, appeared to specifically associate with the heterodimer
complex bound to the hOC VDRE and were not evident in the other
elutions. A 98-kDa protein appeared in elutions from both the hOC and
aPTH VDRE affinity columns, but did not appear in the other columns.
Interestingly, the profile from the aPTH column yielded one unique band
at approximately 160 kDa that was not observed in any of the other
elutions. Analogous profiles from the four columns were obtained from
complexes formed in the absence of ligands in the binding mixtures
(data not shown).

View larger version (41K):
[in this window]
[in a new window]
|
Figure 6. Protein-Protein Contacts Made to Complexes Bound to
Different Response Elements
Binding of rhVDR/rhRXR to the aPTH, dmPTH, or hOC-linked columns, or
rhRXR to a DR+1-linked columns was followed by washing of the
matrices and incubation with MG-63 cell extracts. After washing in
low-salt buffer, the proteins were eluted and analyzed by SDS-PAGE and
silver staining.
|
|
 |
DISCUSSION
|
---|
These results demonstrate a link between the sequence of the
individual nucleotides comprising a steroid response element and the
subsequent activity of a hormone-receptor complex. As determined by the
mobility shift assay, both wild-type and mutant sequences fulfilled the
criteria of specific binding. Interestingly, the 9A7
antibody
directed against the hinge region of the VDR generated a minor, but
significant, supershifted band in the mobility shift assay (Fig. 2
).
Previous work with this antibody under identical conditions using
positively responding VDREs demonstrated that binding of the VDR was
blocked, and no bound or supershifted products were observed (11, 29).
Collectively, these data would be consistent with an altered
conformational change in the VDR and/or an altered polarity of binding
by the heterodimer to these different types of VDREs.
Interference footprinting is predicated on the concept that limited
chemical modifications to singular positions in a DNA binding site may
preclude the ability of a protein to bind to that site, either through
steric, structural, or electrostatic perturbations to the DNA, and thus
be excluded from the bound fraction during the separation procedure.
Interactions of the heterodimer with the wild-type and mutant sequences
appeared highly specific using recombinant sources of receptor
proteins, and there were only minor differences between these sequences
in their ability to compete for binding in the relative competitive
binding electrophoretic mobility shift assay (EMSA). Yet distinct
footprints were evident for each DR+3, suggesting different modes of
interaction by the heterodimeric partners. This implies that the
heterodimer complex may be making additional contacts within the
various sequences with individual nucleotides not examined in this
study or that the bound complex is able to somehow accommodate these
uniquely modified positions. In the case of the aPTH VDRE then, this
latter possibility suggests that any single modification by itself may
not be sufficient to entirely block the complex from still binding to
that sequence.
Surprisingly, the mPTH sequence that placed an adenine residue at
position +7, which is highly conserved in the majority of positive DR+3
VDREs (1), caused only a minor shift in the footprint analysis and
demonstrated only a moderate attenuation of the negative response in
the transcription assay. Conversely, the significant increase in the
degree of interference observed by the G
C swap at position +6 in the
cPTH mutant, together with the observed weak, yet clearly positive
transcriptional response, revealed the relative importance this
position may exert in acting as a switch to distinguish negative
and positive activity. Finally, the dmPTH sequence that exhibited the
strongest interference footprint pattern also displayed the strongest,
positive transcriptional response. This sequence is a perfect direct
repeat of the GGGTCA half-site, highly similar to DNA elements
associated with positive transcriptional responses (1, 7). In addition,
binding site selection analyses indicated that the preferred
DNA-binding sequence of the heterodimer ended in the CA dinucleotide
(positions -3/-2 and +6/+7) for both half-sites (12, 42). However,
other than the dmPTH sequence, there was no strong association between
the order of competition in the EMSA, dmPTH
aPTH
cPTH
mPTH, and the rank order of transcriptional outcomes from strongly
positive to strongly negative: dmPTH
cPTH
mPTH
aPTH. This
suggests that factors other than binding avidity may be playing a role
in determining transcriptional activity.
In contrast to previous reports on other VDREs (20, 21, 22, 43), the
cross-link data place RXR preferentially over the 3'-half of both the
aPTH and dmPTH elements. Preliminary results would indicate that this
arrangement may also hold for a VDRE recently identified in the rat PTH
gene that exhibits striking sequence similarity to the avian element
(J. Russell, S. Ashok, and N. J. Koszewski, manuscript
submitted). Previous data demonstrated that the VDR can bind as
a homodimer to a DR+3 element (9, 11, 12), indicating that the VDR is
capable of occupying the 5' half-site of a VDRE. The retinoid receptors
have also been reported to display an altered polarity in binding to
selected response elements that resulted in enhanced or repressed
transcriptional activity (44). However, an altered polarity by itself
did not restrict the VDR heterodimer complex to a unique
transcriptional outcome in the present study, as exhibited by the
wild-type aPTH and dmPTH sequences that maintained the same polarity,
but with opposing transcriptional responses.
The VDR, like other members of the nuclear receptor gene family, has
also been shown to interact with a variety of accessory proteins
(45, 46, 47, 48, 49, 50). In the studies with the transcriptionally negative aPTH
element, binding to that sequence by the heterodimer generated a weak
interference footprint and promoted unique interaction with a p160
protein. In contrast, heterodimer binding to the positive hOC and dmPTH
sequences, the latter that differed by only two nucleotides from the
aPTH element, failed to exhibit an interaction with this
protein. The elution from the hOC affinity column also revealed
the significant presence of additional proteins at approximately 60 and
54 kDa that appeared specific for this sequence. This may reflect
proteins from human osteoblast-like cells associating with the
recombinant human heterodimer complex bound to a regulatory sequence
from a gene that is naturally expressed in these cells (51). Additional
studies are ongoing, but the relative presence or absence of these
proteins may be involved in the observed negative or positive
transcriptional responses from these specific response elements.
It was noted that essentially identical elution profiles from the
affinity chromatography columns have been obtained from complexes bound
in the presence or absence of added vitamin D hormone. A similar lack
of hormone dependence was also observed in analogous experiments using
HeLa cell nuclear extracts (data not shown). There may be several
reasons to account for this observation, the first of which may be an
inherent lack of sensitivity in this experimental system. Either in the
presence or absence of hormone, a relatively large amount of
affinity-purified hVDR/hRXR complex was immobilized on these VDRE
columns relative to the interacting factors present in the diluted cell
extracts. Also, the binding conditions and washes for the affinity
columns were performed under low-salt conditions. Thus, if the effect
of hormone is to alter the affinity for an interacting protein, then
having such an excess amount of complex in either a hormone-bound or
unbound state under low-salt conditions may simply transcend those
affinity differences and result in an inability to visualize
hormone-dependent interactions. Alternatively, this experiment may be
revealing only those basal, hormone-independent interactions that
occurred in an element-specific fashion. That is, these factors may
associate with the VDR complex as it binds to these VDREs to assist in
achieving the proscribed regulatory response, while the function of the
hormone is to recruit yet additional factors not revealed by this
analysis.
A general working model has appeared in the literature that
incorporates many of the current concepts in explaining activation of
gene expression by the thyroid/retinoid subfamily of nuclear receptors,
to which the VDR belongs (52). The chromatin remodeling scheme proposes
that the unliganded receptor binds to its response element as part of a
multiprotein complex that also includes corepressor or silencer
molecules and histone deacetylases. In this state, transcription of the
target gene is repressed or silenced. Hormone binding is proposed to
alter the conformation of the receptor complex, and transcriptional
coactivators are recruited to the scene along with histone acetylases,
and gene transcription is turned on. While accounting for enhancement
of gene transcription, a question arises as to what factors are
involved that would explain hormone-dependent repression and activation
in the same cell. The present data suggest that an additional detail to
consider is the specific sequence of the DNA-binding site. That is,
beyond the potential role in binding affinity, the subtle and
not-so-subtle differences in DNA sequences capable of binding the VDR
specifically may be acting as allosteric effectors of receptor function
(36, 37, 53, 54). Binding of the VDR to different types of response
elements, therefore, is proposed to elicit conformational changes in
the receptor complex and/or the exposure of different regions of the
molecule to the external environment, similar in concept to agonist or
antagonist binding to the ligand-binding domains of hormone receptors.
Collectively, this suggests that plasticity exists in the VDR/RXR
heterodimer arrangement and corresponding transcriptional response that
is inextricably associated with the exact DNA sequence (55, 56). These
changes in the VDR complex invoked by binding to distinct DNA response
elements may then facilitate the interaction of available cell
type-specific coactivators or corepressors to bring about the desired
transcriptional response.
 |
MATERIALS AND METHODS
|
---|
General
All enzymes were purchased from New England Biolabs (Beverly,
MA).
32P-ATP (6000 Ci/mmol) and
32P-dATP
(3000 Ci/mmol) were purchased from Dupont NEN Research Products
(Wilmington, DE). Oligonucleotides were synthesized at the University
of Kentucky Molecular Structure Analysis Facility with
BamHI- and XbaI-compatible ends and cloned into
pGEM11zf (Promega Corp, Madison, WI). Sequences were confirmed by
dideoxysequencing. Sequences of the top strands are as follows: aPTH,
5'-CTAGAATGAGGGTCAGGAGGGTGTGCTGG; mPTH,
CTAGAATGA-GGGTCAGGAGGGTGAGCTGG; cPTH, CTAGAGAGGGTCAGGAGGGTCTGCG;
dmPTH, CTAGAGAGGGTCAGGA-GGGTCAGCG; hOC,
CTAGATTGGTGACTCACCGGGTGAACGGGGGCATTGCG. The aPTH promoter sequence was
synthesized by PCR and ligated into a commercially available pCAT
expression vector using the SalI and XbaI
restriction sites present in the multiple cloning site. Synthetic
oligonucleotides containing the sequences for wild-type aPTH, the
various aPTH mutants, and wild-type hOC VDREs were excised from
pGEM11zf with the combination of SalI and HindIII
and placed immediately upstream from the aPTH promoter/pCAT construct.
The 9A7
antibody was generously provided by Dr. J. Wesley Pike
(University of Cincinnati), while the anti-RXR
and anti-RXRß
antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz,
CA).
Mobility Shift Assays
Recombinant hVDR- and hRXR
-containing extracts were prepared
from baculovirus-infected Sf9 insect cells as described previously
(11). The cell pellets were homogenized in 6 volumes of buffer [20
mM Tris (pH 7.5), 1 mM EDTA, 2 mM
dithiothreitol (DTT), 350 mM KCl, 10 mM NaF,
100 µM Na3VO4, 0.1 mM
leupeptin, and 10% glycerol] on ice. The cytosols were clarified by
centrifugation at 30,000 x g for 60 min at 4 C,
snap-frozen, and stored at -70 C before use. For radiolabeling, DNA
fragments were excised from the pGEM11zf-based plasmids using the
combination of EcoRI and HindIII restriction
enzymes. Radioactive probes were generated by fill-in labeling
reactions using Klenow fragment and
-32P-dATP. Cytosols
of recombinant hVDR and hRXR
were diluted 1:25 in ice-cold KTEDG
buffer [400 mM KCl, 20 mM Tris (pH 7.5), 1
mM EDTA, 2 mM DTT, and 10% glycerol] before
use. Samples were kept cold, and 1 µl each of diluted extracts was
used in a 20 µl final volume in a buffer that included 100
mM KCl, 20 mM Tris (pH 7.5), 1.5 mM
EDTA, 2 mM DTT, 5% glycerol, 0.5%
3-(3-cholamidopropyl)dimethylammonio-1-propanesulfonate (CHAPS),
10 mM NaF, 100 µM
Na3VO4, 1.0 µg dIdC, and 100 nM
1,25-(OH)2D3. After incubation on ice, the
radiolabeled probes were added and incubation continued for 1 h.
The samples were then applied to cooled, prerun 5% polyacrylamide gels
(29:1) in 0.5x Tris-borate-EDTA buffer, and electrophoresis was
initiated at 14 V/cm for 3 h. Gels were transferred and dried
followed by autoradiography.
Antibodies (1 µl each of undiluted sample) were allowed to incubate
with the gel shift samples for 1 h at 4 C before the addition of
the radiolabeled probes. Cold competition binding reactions were
carried out using the cvitERE (5'-GATCCCTGGTCAGCGTGACCGGAG) and hOC
VDRE (5'-CTAGATTGGTGACTCACCGGGTGAACGGGGGCATTGCG). For the relative
competitive binding experiments, recombinant cytosols were diluted
1:50, and unlabeled competitor oligonucleotide samples were mixed with
radiolabeled wild-type aPTH probe and this combination was added to the
binding reactions.
Interference Assay
The ethylation interference footprints were obtained as
previously described (11). The DNA probes were generated from the
pGEM11z-based plasmids containing the inserted oligonucleotides by
end-labeling linearized, CIP-treated plasmids with polynucleotide
kinase and
-32P-ATP using the combination of
EcoRI and HindIII restriction enzymes. Briefly,
32P-end-labeled DNA probes in 50 mM sodium
cacodylate buffer (pH 8.0) were treated with ethylnitrosourea-saturated
ethanol for 20 min at 55 C. After precipitation with sodium
acetate/ethanol and reprecipitation (three times), the pellets were
washed with 70% ethanol, dried, and resuspended in water. Ethylated
probes were then used in the gel mobility shift assay as above, except
the amounts of probe were increased to 1015 fmol. Acrylamide sections
corresponding to bound and free DNA were excised, and the DNA was
recovered by electrochemical elution and precipitation. Cleavage of the
modified DNA was accomplished by treating with 100 mM
NaOH/0.1 mM EDTA in 10 mM phosphate buffer at
95 C for 30 min followed by neutralization with 3 M sodium
acetate (pH 5.2) and precipitation with ethanol. Samples were separated
by 8% sequencing gels and dried, and autoradiography was performed
followed by densitometric analysis.
Transfection Studies
OK cells were cotransfected by lipofectin as previously
described with the appropriate VDRE-CAT construct (2.5 µg, Fig. 1
)
and cytomegalovirus (CMV)-ß-galactosidase (2.5 µg) plasmids (29).
Analysis of CAT gene transcripts after treatment with
1,25-(OH)2D3 for 24 h was quantified by
ribonuclease protection assay within the same assay. Total RNA from OK
cells transfected with the various PTH-CAT and CMV-ß-galactosidase
plasmid constructs was prepared by extraction with phenol-guanidinium
thiocyanate. The RNA extracts were incubated with DNase I for 5 min at
room temperature and ethanol precipitated. The RNA pellets were
incubated with radiolabeled RNA probes (158 bases for CAT and 370 bases
for ß-galactosidase) in 20 µl of buffer containing 80% formamide,
100 mM sodium citrate, pH 6.4, 300 mM sodium
acetate, pH 6.4, 1 mM EDTA, overnight at 43 C. The
hybridization mixtures were digested with a combination of ribonuclease
A and ribonuclease T1 at 37 C for 30 min. The protected RNA hybrids
were precipitated with propanol-guanidinium thiocyanate and
separated on 6% nondenaturing polyacrylamide gels. The gels were dried
and exposed to x-ray film for 6 h at -80 C. The resulting
autoradiograms were quantified by densitometric scanning, and values
for the CAT gene transcripts were normalized with respect to the values
for cotransfected ß-galactosidase gene transcripts.
UV Cross-Linking
The 5'- or 3'-oligonucleotides (5':
GCATCTAGAATGAGGGBrUCAGG; 3':
AGGGBrUGBrUGCTGGATCCCTCGA) of the aPTH were
end-labeled with
-32P-ATP and T4 polynucleotide kinase.
The labeled oligonucleotides were mixed with an excess of the other
unlabeled oligonucleotide and annealed to the complementary sequence.
After hybridization, the double-stranded oligonucleotides were purified
by 8% PAGE and recovered by electroelution. The hybridized DNA
fragments were then included in incubations as described above for the
mobility shift assay except the amount of recombinant cytosols was
increased 2.5-fold, and 100,000 cpm of gapped, radiolabeled probes were
added. The sample tubes were maintained on ice and irradiated for 45
min at a wavelength of 254 nm. After irradiation, the binding reactions
were mixed with 2x SDS-PAGE loading buffer and denatured at 95 C for 5
min, and the proteins were separated by 10% SDS-PAGE. After
electrophoresis the gels were fixed and dried, and autoradiography was
performed. Cross-linking probes for the dmPTH (5':
CCGCATCTAGAGAGGGBrUCAGG; 3':
AGGGBrUCAGCGGATCCCTCGAG) were prepared and treated in an
analogous fashion.
Affinity Chromatography Studies
Oligonucleotide probes biotinlyated at the 5'-end for aPTH and
dmPTH were synthesized as above, annealed to their complementary
strand, and bound to streptavidin-agarose beads. In addition, a DR+1
matrix was similarly prepared (5'-GATCCGGGTAGGGGTCAGAGGTCACTCGT).
Binding reactions of a mixture of rhVDR and rhRXR
in the presence of
1,25-(OH)2D3 or rhRXR
alone in the presence
of 9-cis-retinoic acid (10 µM) were prepared
as outlined above, but in amounts to completely saturate binding to the
response elements present in each column. After incubation of the
recombinant proteins with the agarose matrices for 60 min at 4 C, the
matrices were washed with approximately 50 volumes of KTEDG-200 buffer.
After this, the columns were reequilibrated in 10 volumes of KTEDG-60
buffer. Whole-cell extracts were prepared from human osteosarcoma MG-63
cells as outlined above and diluted to 60 mM KCl
concentration. The MG-63 extracts were then mixed with the agarose
matrices at 4 C for 60 min and then washed with approximately 50
volumes of KTEDG-60 buffer. The bound proteins were subsequently eluted
by incubation with KTEDG-400 buffer, denatured, separated by 10%
SDS-PAGE, and silver stained.
 |
ACKNOWLEDGMENTS
|
---|
The authors would like to Ms. Holli Gravatte for her excellent
technical assistance and Dr. M. C. Langub for his critical review
of this manuscript.
 |
FOOTNOTES
|
---|
Address requests for reprints to: Dr. Nicholas J. Koszewski, University of Kentucky Medical Center, Department of Internal Medicine, Division of Nephrology, Bone and Mineral Metabolism, 800 Rose Street, Lexington, Kentucky 40536-0084. E-mail: njhosz0{at}pop.uky.edu
This work was supported by NIH Grants DK-47883 (N.J.K.), DK-38422
(J.R.), and Dialysis Clinic Incorporated (N.J.K.).
Received for publication May 14, 1998.
Revision received November 20, 1998.
Accepted for publication November 30, 1998.
 |
REFERENCES
|
---|
-
Haussler MR, Whitfield GK, Haussler CA, Hsieh J-C,
Thompson PD, Selznick SH, Dominguez CE, Jurutka PW 1998 The nuclear
vitamin D receptor: biological and molecular regulatory properties
revealed. J Bone Miner Res 13:325349[Medline]
-
Kerner SA, Scott RA, Pike JW 1989 Sequence elements in the
human osteocalcin gene confer basal activation and inducible response
to hormonal vitamin D3. Proc Natl Acad Sci USA 86:44554459[Abstract]
-
Noda M, Vogel RL, Craig AM, Prahl J, DeLuca HF, Denhardt DT 1990 Identification of a DNA sequence responsible for binding of the
1,25- dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3
enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin)
gene expression. Proc Natl Acad Sci USA 87:99959999[Abstract]
-
Ohyama Y, Ozono K, Uchida M, Shinki T, Kato S, Suda T,
Yamamoto O, Noshiro M, Kato Y 1994 Identification of a vitamin
D-responsive element in the 5'-flanking region of the rat
25-hydroxyvitamin D3 24-hydroxylase gene. J Biol Chem 269:1054510550[Abstract/Free Full Text]
-
Ozono K, Liao J, Kerner SA, Scott RA, Pike JW 1990 The
vitamin D-responsive element in the human osteocalcin gene. Association
with a nuclear proto-oncogene enhancer. J Biol Chem 265:2188121888[Abstract/Free Full Text]
-
Terpening CM, Haussler CA, Jurutka PW, Galligan MA, Komm BS,
Haussler MR 1991 The vitamin D-responsive element in the rat bone Gla
protein gene is an imperfect direct repeat that cooperates with other
cis-elements in 1,25- dihydroxyvitamin
D3-mediated transcriptional activation. Mol Endocrinol 5:373385[Abstract]
-
Umesono K, Murakami KK, Thompson CC, Evans RM 1991 Direct
repeats as selective response elements for the thyroid hormone,
retinoic acid, and vitamin D3 receptors. Cell 65:12551266[Medline]
-
Zierold C, Darwish HM, DeLuca HF 1995 Two vitamin D response
elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase
promoter. J Biol Chem 270:16751678[Abstract/Free Full Text]
-
Cheskis B, Freedman LP 1994 Ligand modulates the conversion
of DNA-bound vitamin D3 receptor (VDR) homodimers into
VDR-retinoid x receptor heterodimers. Mol Cell Biol 14:33293338[Abstract]
-
Freedman LP, Arce V, Perez Fernandez R 1994 DNA sequences that
act as high affinity targets for the vitamin D3 receptor in
the absence of the retinoid X receptor. Mol Endocrinol 8:265273[Abstract]
-
Koszewski NJ, Reinhardt TA, Horst RL 1996 Vitamin D receptor
interactions with the murine osteopontin response element. J Steroid
Biochem Mol Biol 59:377388[CrossRef][Medline]
-
Nishikawa J, Kitaura M, Matsumoto M, Imagawa M, Nishihara T 1994 Difference and similarity of DNA sequence recognized by VDR
homodimer and VDR/RXR heterodimer. Nucleic Acids Res 22:29022907[Abstract]
-
Liao J, Ozono K, Sone T, McDonnell DP, Pike JW 1990 Vitamin D
receptor interaction with specific DNA requires a nuclear protein and
1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 87:97519755[Abstract]
-
Sone T, Kerner S, Pike JW 1991 Vitamin D receptor interaction
with specific DNA. Association as a 1,25-dihydroxyvitamin
D3-modulated heterodimer. J Biol Chem 266:2329623305[Abstract/Free Full Text]
-
Sone T, Ozono K, Pike JW 1991 A 55-kilodalton accessory factor
facilitates vitamin D receptor DNA binding. Mol Endocrinol 5:15781586[Abstract]
-
Ross TK, Moss VE, Prahl JM, DeLuca HF 1992 A nuclear protein
essential for binding of rat 1,25-dihydroxyvitamin D3 receptor to its
response elements. Proc Natl Acad Sci USA 89:256260[Abstract]
-
MacDonald PN, Dowd DR, Nakajima S, Galligan MA, Reeder MC,
Haussler CA, Ozato K, Haussler MR 1993 Retinoid X receptors stimulate
and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin
D3-activated expression of the rat osteocalcin gene. Mol
Cell Biol 13:59075917[Abstract]
-
Munder M, Herzberg IM, Zierold C, Moss VE, Hanson K,
Clagett-Dame M, DeLuca HF 1995 Identification of the porcine intestinal
accessory factor that enables DNA sequence recognition by vitamin D
receptor. Proc Natl Acad Sci USA 92:27952799[Abstract]
-
Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM,
Kim SY, Boutin JM, Glass CK, Rosenfeld MG 1991 RXR beta: a coregulator
that enhances binding of retinoic acid, thyroid hormone, and vitamin D
receptors to their cognate response elements. Cell 67:12511266[Medline]
-
Jin CH, Pike JW 1996 Human vitamin D receptor-dependent
transactivation in Saccharomyces cerevisiae requires
retinoid X receptor. Mol Endocrinol 10:196205[Abstract]
-
Lemon BD, Freedman LP 1996 Selective effects of ligands on
vitamin D3 receptor- and retinoid X receptor-mediated gene activation
in vivo. Mol Cell Biol 16:10061016[Abstract]
-
Staal A, van WAJ, Birkenhager JC, Pols HA, Prahl J, DeLuca H,
Gaub MP, Lian JB, Stein GS, van LJP, Stein JL 1996 Distinct
conformations of vitamin D receptor/retinoid X receptor-
heterodimers are specified by dinucleotide differences in the vitamin
D-responsive elements of the osteocalcin and osteopontin genes. Mol
Endocrinol 10:14441456[Abstract]
-
Alroy I, Towers TL, Freedman LP 1995 Transcriptional
repression of the interleukin-2 gene by vitamin D3: direct inhibition
of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell
Biol 15:57895799[Abstract]
-
Falzon M 1996 DNA sequences in the rat parathyroid
hormone-related peptide gene responsible for 1,25-dihydroxyvitamin
D3-mediated transcriptional repression. Mol Endocrinol 10:672681[Abstract]
-
Kremer R, Sebag M, Champigny C, Meerovitch K, Hendy GN, White
J, Goltzman D 1996 Identification and characterization of
1,25-dihydroxyvitamin D3-responsive repressor sequences in
the rat parathyroid hormone-related peptide gene. J Biol Chem 271:1631016316[Abstract/Free Full Text]
-
Li Q, Gardner DG 1994 Negative regulation of the human atrial
natriuretic peptide gene by 1,25-dihydroxyvitamin D3.
J Biol Chem 269:49344939[Abstract/Free Full Text]
-
Peleg S, Abruzzese RV, Cooper CW, Gagel RF 1993 Down-regulation of calcitonin gene transcription by vitamin D requires
two widely separated enhancer sequences. Mol Endocrinol 7:9991008[Abstract]
-
Demay MB, Kiernan MS, DeLuca HF, Kronenberg HM 1992 Sequences
in the human parathyroid hormone gene that bind the
1,25-dihydroxyvitamin D3 receptor and mediate
transcriptional repression in response to 1,25-dihydroxyvitamin
D3. Proc Natl Acad Sci USA 89:80978101[Abstract]
-
Liu SM, Koszewski N, Lupez M, Malluche HH, Olivera A, Russell
J 1996 Characterization of a response element in the 5'-flanking region
of the avian (chicken) PTH gene that mediates negative regulation of
gene transcription by 1,25-dihydroxyvitamin D3 and binds
the vitamin D3 receptor. Mol Endocrinol 10:206215[Abstract]
-
Okazaki T, Igarashi T, Kronenberg HM 1988 5'-flanking region
of the parathyroid hormone gene mediates negative regulation by
1,25-(OH)2 vitamin D3. J Biol Chem 263:22032208[Abstract/Free Full Text]
-
Okazaki T, Zajac JD, Igarashi T, Ogata E, Kronenberg HM 1991 Negative regulatory elements in the human parathyroid hormone gene.
J Biol Chem 266:2190321910[Abstract/Free Full Text]
-
Hawa NS, ORiordan JL, Farrow SM 1996 Functional analysis of
vitamin D response elements in the parathyroid hormone gene and a
comparison with the osteocalcin gene. Biochem Biophys Res Commun 228:352357[CrossRef][Medline]
-
Mackey SL, Heymont JL, Kronenberg HM, Demay MB 1996 Vitamin D receptor binding to the negative human parathyroid hormone
vitamin D response element does not require the retinoid X receptor.
Mol Endocrinol 10:298305[Abstract]
-
Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR 1990 Transcription factor interactions: selectors of positive or negative
regulation from a single DNA element. Science 249:12661272[Medline]
-
Sakai DD, Helms S, Carlstedt-Duke J, Gustafsson JA, Rottman
FM, Yamamoto KR 1988 Hormone-mediated repression: a negative
glucocorticoid response element from the bovine prolactin gene. Genes
Dev 2:11441154[Abstract]
-
Starr DB, Matsui W, Thomas JR, Yamamoto KR 1996 Intracellular
receptors use a common mechanism to interpret signaling information at
response elements. Genes Dev 10:12711283[Abstract]
-
Lefstin JA, Thomas JR, Yamamoto KR 1994 Influence of a steroid
receptor DNA-binding domain on transcriptional regulatory functions.
Genes Dev 8:28422856[Abstract]
-
Schrader M, Muller KM, Nayeri S, Kahlen JP, Carlberg C 1994 Vitamin D3-thyroid hormone receptor heterodimer polarity directs ligand
sensitivity of transactivation. Nature 370:382386[CrossRef][Medline]
-
Zechel C, Shen XQ, Chen JY, Chen ZP, Chambon P, Gronemeyer H 1994 The dimerization interfaces formed between the DNA binding domains
of RXR, RAR and TR determine the binding specificity and polarity of
the full-length receptors to direct repeats. EMBO J 13:14251433[Abstract]
-
Heery DM, Pierrat B, Gronemeyer H, Chambon P, Losson R 1994 Homo- and heterodimers of the retinoid X receptor (RXR) activated
transcription in yeast. Nucleic Acids Res 22:726731[Abstract]
-
Mader S, Chen JY, Chen Z, White J, Chambon P, Gronemeyer H 1993 The patterns of binding of RAR, RXR and TR homo- and heterodimers
to direct repeats are dictated by the binding specificites of the DNA
binding domains. EMBO J 12:50295041[Abstract]
-
Colnot S, Lambert M, Blin C, Thomasset M, Perret C 1995 Identification of DNA sequences that bind retinoid X
receptor-1,25(OH)2D3-receptor heterodimers with
high affinity. Mol Cell Endocrinol 113:8998[CrossRef][Medline]
-
Kurokawa R, Yu VC, Naar A, Kyakumoto S, Han Z, Silverman S,
Rosenfeld MG, Glass CK 1993 Differential orientations of the
DNA-binding domain and carboxy-terminal dimerization interface regulate
binding site selection by nuclear receptor heterodimers. Genes Dev 7:14231435[Abstract]
-
Kurokawa R, DiRenzo J, Boehm M, Sugarman J, Gloss B, Rosenfeld
MG, Heyman RA, Glass CK 1994 Regulation of retinoid signalling by
receptor polarity and allosteric control of ligand binding. Nature 371:528531[CrossRef][Medline]
-
Hong H, Kohli K, Garabedian MJ, Stallcup MR 1997 GRIP1, a
transcriptional coactivator for the AF-2 transactivation domain of
steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17:27352744[Abstract]
-
Blanco JC, Wang IM, Tsai SY, Tsai MJ, OMalley BW, Jurutka
PW, Haussler MR, Ozato K 1995 Transcription factor TFIIB and the
vitamin D receptor cooperatively activate ligand-dependent
transcription. Proc Natl Acad Sci USA 92:15351539[Abstract]
-
Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD 1995 Interaction of thyroid-hormone receptor with a conserved
transcriptional mediator. Nature 374:9194[CrossRef][Medline]
-
MacDonald PN, Sherman DR, Dowd DR, Jefcoat SC, Jr, DeLisle RK 1995 The vitamin D receptor interacts with general transcription factor
IIB. J Biol Chem 270:47484752[Abstract/Free Full Text]
-
vom Baur E, Zechel C, Heery D, Heine MJ, Garnier JM, Vivat V,
Le Douarin B, Gronemeyer H, Chambon P, Losson R 1996 Differential
ligand-dependent interactions between the AF-2 activating domain of
nuclear receptors and the putative transcriptional intermediary
factors mSUG1 and TIF1. EMBO J 15:110124[Abstract]
-
Baudino TA, Kraichely DM, Jefcoat SC, Jr, Winchester SK,
Partridge NC, MacDonald PN 1998 Isolation and characterization of a
novel coactivator protein, NCoA-62, involved in vitamin D-mediated
transcription. J Biol Chem 273:1643416441[Abstract/Free Full Text]
-
Clover J, Gowen M 1994 Are MG-63 and HOS TE85 human
osteosarcoma cell lines representative models of the osteoblastic
phenotype? Bone 15:585591[Medline]
-
Perlmann T, Evans RM 1997 Nuclear receptors in Sicily: all in
the famiglia. Cell 90:391397[Medline]
-
Rajaram N, Kerppola TK 1997 DNA bending by Fos-Jun and the
orientation of heterodimer binding depend on the sequence of the AP-1
site. EMBO J 16:29172925[Abstract/Free Full Text]
-
Huang J, Blackwell TK, Kedes L, Weintraub H 1996 Differences
between MyoD DNA binding and activation site requirements revealed by
functional random sequence selection. Mol Cell Biol 16:38933900[Abstract]
-
Kurokawa R, Soderstrom M, Horlein A, Halachmi S, Brown M,
Rosenfeld MG, Glass CK 1995 Polarity-specific activities of retinoic
acid receptors determined by a co-repressor. Nature 377:451454[CrossRef][Medline]
-
Misra V, Walter S, Yang P, Hayes S, POH 1996 Conformational
alteration of Oct-1 upon DNA binding dictates selectivity in
differential interactions with related transcriptional coactivators.
Mol Cell Biol 16:44044413[Abstract]